Physician profile
Jinling Wu
NPI 1841795713
$3,216.65
in general payments reported to CMS, 2019-2025
10 companies · $791 in 2025
The $791 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $53.05 · 2022: $49.05 · 2023: $31.74 · 2024: $2,167 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Travel and Lodging: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.08 |
| Travel and Lodging | $1,075.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,932.56 | 2021-2025 | Simulus, Freestyle, Sonicision |
| Edwards Lifesciences Corporation | $399.03 | 2024-2025 | Inspiris Resilia Aortic Valve, Konect Resilia |
| Atricure, INC. | $178.42 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Becton, Dickinson and Company | $148.21 | 2025 | Progel Applicator Spray Tips |
| Merck Sharp & Dohme LLC | $140.30 | 2019-2021 | |
| Artivion, INC. | $139.99 | 2025 | Amds-Ascyrus Medical |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Imfinzi |
| Zimmer Biomet Holdings, INC. | $84.14 | 2025 | Sternalock 360 System |
| Takeda Pharmaceuticals U.S.A., INC. | $49.05 | 2022 | |
| Nestle Healthcare Nutrition INC. | $19.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinling Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.